Amgen CEO nabs pay raise thanks to Horizon deal. Does that incentivize aggressive M&A?

Amgen CEO Robert Bradway scored a 5.8% increase in overall compensation last year mostly thanks to the company’s acquisition of Horizon Therapeutics.

For 2023, Amgen granted Bradway $22.6 million in total pay, compared with $21.4 million for 2022, a securities filing shows.